US Stock MarketDetailed Quotes

ACRS Aclaris Therapeutics

Watchlist
  • 1.320
  • +0.010+0.76%
Close Jul 19 16:00 ET
  • 1.302
  • -0.018-1.36%
Post 19:39 ET
94.07MMarket Cap-1211P/E (TTM)

Aclaris Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-5.14%2.4M
5.03%31.25M
126.62%17.57M
-51.19%9.28M
22.32%1.87M
73.98%2.53M
340.05%29.75M
416.52%7.75M
1,046.35%19.02M
-16.23%1.53M
Operating revenue
-5.14%2.4M
5.95%31.25M
131.55%17.57M
-51.12%9.28M
24.77%1.87M
77.65%2.53M
344.27%29.5M
415.84%7.59M
1,065.62%18.99M
-6.72%1.5M
Cost of revenue
-1.55%1.84M
51.18%18.08M
324.57%6.43M
-0.38%8.19M
49.06%1.59M
61.82%1.87M
153.77%11.96M
31.77%1.51M
648.23%8.22M
-15.44%1.07M
Gross profit
-15.33%558K
-25.99%13.17M
78.59%11.14M
-89.90%1.09M
-39.78%277K
121.14%659K
768.75%17.79M
1,672.44%6.24M
1,827.68%10.8M
-18.00%460K
Operating expense
-46.81%16.69M
25.78%129.48M
23.54%34.86M
4.09%30.67M
31.05%32.57M
53.77%31.38M
52.67%102.95M
34.08%28.22M
47.68%29.47M
80.53%24.85M
Selling and administrative expenses
-22.14%6.84M
23.73%31.1M
14.95%8.21M
16.94%6.8M
20.10%7.3M
44.12%8.79M
6.41%25.13M
2.92%7.15M
-2.78%5.81M
3.49%6.08M
-General and administrative expense
-22.14%6.84M
23.73%31.1M
14.95%8.21M
16.94%6.8M
20.10%7.3M
44.12%8.79M
6.41%25.13M
2.92%7.15M
-2.78%5.81M
3.49%6.08M
Research and development costs
-56.41%9.85M
26.44%98.38M
26.45%26.65M
0.93%23.88M
34.59%25.28M
57.88%22.59M
77.60%77.81M
49.43%21.07M
69.26%23.66M
137.80%18.78M
Operating profit
47.49%-16.13M
-36.59%-116.31M
-7.91%-23.72M
-58.42%-29.58M
-32.39%-32.29M
-52.77%-30.72M
-30.24%-85.15M
-6.21%-21.98M
3.72%-18.67M
-84.72%-24.39M
Net non-operating interest income expense
Other net income (expense)
-131.67%-810K
1,665.91%27.47M
486.49%21.86M
125.27%323K
-29.44%2.73M
94.08%2.56M
93.12%-1.75M
-167.93%-5.66M
27.01%-1.28M
177.94%3.86M
Special income (charges)
-450.00%-2.8M
503.34%18.96M
377.06%19.67M
9.41%-1.99M
-85.91%479K
-33.33%800K
80.69%-4.7M
-222.73%-7.1M
-144.44%-2.2M
170.83%3.4M
-Less：Restructuring and merger&acquisition
450.00%2.8M
-672.34%-26.9M
-470.42%-26.3M
-22.73%1.7M
55.88%-1.5M
33.33%-800K
-80.69%4.7M
222.73%7.1M
144.44%2.2M
-170.83%-3.4M
-Less:Impairment of capital assets
----
--6.63M
----
----
----
----
--0
----
----
----
-Write off
----
--1.31M
--0
--293K
--1.02M
----
--0
--0
--0
--0
Other non- operating income (expenses)
13.20%1.99M
188.83%8.51M
51.59%2.19M
151.19%2.32M
386.15%2.25M
1,389.83%1.76M
357.97%2.95M
1,522.47%1.44M
208.34%922K
398.06%462K
Income before tax
39.84%-16.94M
-2.23%-88.85M
93.28%-1.86M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
4.35%-86.91M
-21.18%-27.64M
5.65%-19.95M
-13.06%-20.53M
Income tax
-367K
0
Net income
39.84%-16.94M
-1.81%-88.48M
94.60%-1.49M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
4.35%-86.91M
-21.18%-27.64M
5.65%-19.95M
-13.06%-20.53M
Net income continuous Operations
39.84%-16.94M
-1.81%-88.48M
94.60%-1.49M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
4.35%-86.91M
-21.18%-27.64M
5.65%-19.95M
-13.06%-20.53M
Minority interest income
Net income attributable to the parent company
39.84%-16.94M
-1.81%-88.48M
94.60%-1.49M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
4.35%-86.91M
-21.18%-27.64M
5.65%-19.95M
-13.06%-20.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
39.84%-16.94M
-1.81%-88.48M
94.60%-1.49M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
4.35%-86.91M
-21.18%-27.64M
5.65%-19.95M
-13.06%-20.53M
Basic earnings per share
42.86%-0.24
4.51%-1.27
95.12%-0.02
-36.67%-0.41
-35.48%-0.42
-35.48%-0.42
16.88%-1.33
-10.81%-0.41
14.29%-0.3
8.82%-0.31
Diluted earnings per share
42.86%-0.24
4.51%-1.27
95.12%-0.02
-36.67%-0.41
-35.48%-0.42
-35.48%-0.42
16.88%-1.33
-10.81%-0.41
14.29%-0.3
8.82%-0.31
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -5.14%2.4M5.03%31.25M126.62%17.57M-51.19%9.28M22.32%1.87M73.98%2.53M340.05%29.75M416.52%7.75M1,046.35%19.02M-16.23%1.53M
Operating revenue -5.14%2.4M5.95%31.25M131.55%17.57M-51.12%9.28M24.77%1.87M77.65%2.53M344.27%29.5M415.84%7.59M1,065.62%18.99M-6.72%1.5M
Cost of revenue -1.55%1.84M51.18%18.08M324.57%6.43M-0.38%8.19M49.06%1.59M61.82%1.87M153.77%11.96M31.77%1.51M648.23%8.22M-15.44%1.07M
Gross profit -15.33%558K-25.99%13.17M78.59%11.14M-89.90%1.09M-39.78%277K121.14%659K768.75%17.79M1,672.44%6.24M1,827.68%10.8M-18.00%460K
Operating expense -46.81%16.69M25.78%129.48M23.54%34.86M4.09%30.67M31.05%32.57M53.77%31.38M52.67%102.95M34.08%28.22M47.68%29.47M80.53%24.85M
Selling and administrative expenses -22.14%6.84M23.73%31.1M14.95%8.21M16.94%6.8M20.10%7.3M44.12%8.79M6.41%25.13M2.92%7.15M-2.78%5.81M3.49%6.08M
-General and administrative expense -22.14%6.84M23.73%31.1M14.95%8.21M16.94%6.8M20.10%7.3M44.12%8.79M6.41%25.13M2.92%7.15M-2.78%5.81M3.49%6.08M
Research and development costs -56.41%9.85M26.44%98.38M26.45%26.65M0.93%23.88M34.59%25.28M57.88%22.59M77.60%77.81M49.43%21.07M69.26%23.66M137.80%18.78M
Operating profit 47.49%-16.13M-36.59%-116.31M-7.91%-23.72M-58.42%-29.58M-32.39%-32.29M-52.77%-30.72M-30.24%-85.15M-6.21%-21.98M3.72%-18.67M-84.72%-24.39M
Net non-operating interest income expense
Other net income (expense) -131.67%-810K1,665.91%27.47M486.49%21.86M125.27%323K-29.44%2.73M94.08%2.56M93.12%-1.75M-167.93%-5.66M27.01%-1.28M177.94%3.86M
Special income (charges) -450.00%-2.8M503.34%18.96M377.06%19.67M9.41%-1.99M-85.91%479K-33.33%800K80.69%-4.7M-222.73%-7.1M-144.44%-2.2M170.83%3.4M
-Less：Restructuring and merger&acquisition 450.00%2.8M-672.34%-26.9M-470.42%-26.3M-22.73%1.7M55.88%-1.5M33.33%-800K-80.69%4.7M222.73%7.1M144.44%2.2M-170.83%-3.4M
-Less:Impairment of capital assets ------6.63M------------------0------------
-Write off ------1.31M--0--293K--1.02M------0--0--0--0
Other non- operating income (expenses) 13.20%1.99M188.83%8.51M51.59%2.19M151.19%2.32M386.15%2.25M1,389.83%1.76M357.97%2.95M1,522.47%1.44M208.34%922K398.06%462K
Income before tax 39.84%-16.94M-2.23%-88.85M93.28%-1.86M-46.66%-29.26M-44.01%-29.57M-49.87%-28.16M4.35%-86.91M-21.18%-27.64M5.65%-19.95M-13.06%-20.53M
Income tax -367K0
Net income 39.84%-16.94M-1.81%-88.48M94.60%-1.49M-46.66%-29.26M-44.01%-29.57M-49.87%-28.16M4.35%-86.91M-21.18%-27.64M5.65%-19.95M-13.06%-20.53M
Net income continuous Operations 39.84%-16.94M-1.81%-88.48M94.60%-1.49M-46.66%-29.26M-44.01%-29.57M-49.87%-28.16M4.35%-86.91M-21.18%-27.64M5.65%-19.95M-13.06%-20.53M
Minority interest income
Net income attributable to the parent company 39.84%-16.94M-1.81%-88.48M94.60%-1.49M-46.66%-29.26M-44.01%-29.57M-49.87%-28.16M4.35%-86.91M-21.18%-27.64M5.65%-19.95M-13.06%-20.53M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 39.84%-16.94M-1.81%-88.48M94.60%-1.49M-46.66%-29.26M-44.01%-29.57M-49.87%-28.16M4.35%-86.91M-21.18%-27.64M5.65%-19.95M-13.06%-20.53M
Basic earnings per share 42.86%-0.244.51%-1.2795.12%-0.02-36.67%-0.41-35.48%-0.42-35.48%-0.4216.88%-1.33-10.81%-0.4114.29%-0.38.82%-0.31
Diluted earnings per share 42.86%-0.244.51%-1.2795.12%-0.02-36.67%-0.41-35.48%-0.42-35.48%-0.4216.88%-1.33-10.81%-0.4114.29%-0.38.82%-0.31
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg